Wagner Michael, Rudakova Elena, Volk Tilmann
Institut für Zelluläre und Molekulare Physiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Waldstrasse 6, 91054, Erlangen, Germany.
Pflugers Arch. 2008 Nov;457(2):339-49. doi: 10.1007/s00424-008-0518-1. Epub 2008 May 27.
Mineralocorticoid receptor (MR) activation modulates cardiac L-type Ca(2+) current (I (CaL)) and transient outward K(+) current (I (to)). The exact circumstances of MR activation, however, remain elusive. Here, we investigate the influence of corticosteroids on MR-mediated changes in cellular electrophysiology. In vitro incubation of adult rat ventricular myocytes with the MR agonist aldosterone (100 nM, 24 h) increased I (CaL) density by 34% (n = 16; p < 0.01). This effect was abrogated by co-incubation with the MR antagonist spironolactone (10 muM). To investigate whether an increase in serum aldosterone concentration is sufficient for an increase in I (CaL) in vivo, rats were subjected to low Na(+) diet (LSD, 0.013% Na(+)) for 28 days. This increased serum aldosterone concentration from 0.19 +/- 0.04 nM (n = 6) in control animals (0.3% Na(+), CSD) to 16.1 +/- 2.1 nM (n = 6; p < 0.0001). Strikingly, I (CaL) density was similar in both CSD and LSD rats (-12.9 +/- 0.9 pA pF(-1), n = 18 and -13.7 +/- 1.1 pA pF(-1), n = 16, respectively), as was I (to) density. In vitro, the glucocorticoid corticosterone (1 microM) also increased I (CaL) and this effect was blocked by spironolactone (10 microM). Co-incubation with corticosterone (1 microM, the normal serum concentration) and aldosterone (100 nM, mimicking low Na(+) intake) did not further increase I (CaL) compared to corticosterone alone. Moreover, co-incubation of myocytes with N-acetylcysteine (10 mM) prevented the aldosterone (100 nM) or corticosterone (1 microM)-induced increase in I (CaL). In conclusion, an increase in serum aldosterone concentration in response to LSD is not sufficient for an increase in I (CaL) density in cardiomyocytes in vivo. This is supported in vitro by the absence of an effect of aldosterone on I (CaL) in the presence of a physiological concentration of corticosterone. Moreover, the cellular redox state may modulate MR activation.
盐皮质激素受体(MR)激活可调节心脏L型钙电流(I(CaL))和瞬时外向钾电流(I(to))。然而,MR激活的确切情况仍不清楚。在此,我们研究皮质类固醇对MR介导的细胞电生理变化的影响。用MR激动剂醛固酮(100 nM,24小时)对成年大鼠心室肌细胞进行体外孵育,可使I(CaL)密度增加34%(n = 16;p < 0.01)。与MR拮抗剂螺内酯(10 μM)共同孵育可消除这种作用。为了研究血清醛固酮浓度升高是否足以在体内增加I(CaL),将大鼠置于低钠饮食(LSD,0.013% Na+)28天。这使血清醛固酮浓度从对照动物(0.3% Na+,CSD)的0.19±0.04 nM(n = 6)增加到16.1±2.1 nM(n = 6;p < 0.0001)。令人惊讶的是,CSD和LSD大鼠的I(CaL)密度相似(分别为-12.9±0.9 pA pF-1,n = 18和-13.7±1.1 pA pF-1,n = 16),I(to)密度也是如此。在体外,糖皮质激素皮质酮(1 μM)也增加I(CaL),且这种作用被螺内酯(10 μM)阻断。与皮质酮(1 μM,正常血清浓度)和醛固酮(100 nM,模拟低钠摄入)共同孵育相比,单独使用皮质酮时I(CaL)没有进一步增加。此外,将肌细胞与N-乙酰半胱氨酸(10 mM)共同孵育可阻止醛固酮(100 nM)或皮质酮(1 μM)诱导的I(CaL)增加。总之,对LSD反应的血清醛固酮浓度升高不足以在体内增加心肌细胞的I(CaL)密度。在体外,生理浓度的皮质酮存在时醛固酮对I(CaL)无作用支持了这一点。此外,细胞氧化还原状态可能调节MR激活。